Introduction: Neurotransmitter systems, involved in depressive disorders, are in line with personality dimensions. The present study aimed at comparing personality dimensions of individuals with major depressive disorders using Selective Serotonin Reuptake Inhibitors (SSRIs) drugs with those of individuals using Tricyclic Antidepressant (TCA) in combination with SSRIs. Methods: The present study was descriptive-comparative, which was carried out during year 2017 in two groups of 37 patients with major depressive disorder, who used Selective Serotonin Reuptake Inhibitors (SSRIs) with those of individuals using Tricyclic Antidepressant (TCA) in combination with SSRIs. Samples were selected by the convince sampling method from Baqiyatallah al-Azam hospital, Taleghani, Faculty of Psychology of Tehran University and Sepehr clinics. For data collection, the "Temperament and Character Inventory" (TCI-56) was used. The validity and reliability of this inventory has been confirmed in previous studies. Data were analyzed with the SPSS version 24 software. Results: The two groups did not differ significantly in terms of personality traits. In other words, the mean personality characteristics did not differ significantly between the two groups (P < 0.01). Conclusions: According to the results of this study, prescribing both drug groups is recommended to increase the desirable personality scores and to reduce undesirable scores in the treatment of patients with depressive disorder.
Background: Methods of achieving mindfulness have been implemented by slowing down movement, creating stillness, and following the traditional teachings of Buddhism. The long-term effectiveness of traditional mindfulness methods on anxiety and depression has been associated with conflicting results. Recently, bodily, dynamic, and objective interventions while moving and playing on the unconscious and strengthening consciousness for the integration of mind and body have been suggested. Can these therapeutic exercises change the abnormal patterns of an anxious and depressed personality? Aims: This study aimed to study the effectiveness of mindful sensorimotor interventions in treating abnormal personality patterns leading to anxiety and depression in clients seeking psychotherapy. Methods: This research is an explanatory mixed-method study. The first study was a quasiexperimental study with pre-test and post-test. The statistical population of the study was the clients of psychology clinics in Tehran. a sample of 20 (7 women and 13 men) of the clients of a psychology clinic in Tehran responded to Castello-Comrey (1967) anxiety and depression questionnaires before and after eight weeks of mindful sensorimotor interventions (Kashanaki et al., 2021). In the second study, during and after mindful sensorimotor interventions, personality disorders, mental health, and personality traits predicting anxiety and depression in one client were assessed by the SWAP personality test (Shedler and Westen, 2007). Results: The results of a correlated t-test showed that mindful sensorimotor interventions are effective in reducing anxiety (p < 0.00001) and depression (p < 0.05). The second study showed that the patient changes his pathological personality patterns and personality disorder by interventions; this intervention transformed immature defenses into more mature defenses and increased mental health factors in him, which led to a decrease in anxiety and depression. Conclusion: The results of this study showed the effectiveness of mindful sensorimotor interventions in reducing anxiety and depression. These challenging interventions and a variety of games are likely to empower and increase the capacity of the mind and body and motivate them to endure anxiety and cope with depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.